[Patho- and morphogenesis of pyo-inflammatory diseases of the adnexa uteri]

Arkhiv patologii · 1994 · vol. 55(1) , pp. 43–8 · PMID:7980040 · W2443304336
Other OA: closed CC0
View on OpenAlex View on PubMed
⚙ AI-generated summary by qwen3.7-flash, 2026-10-11 ⓘ

In 87 women with chronic adnexal inflammation, researchers identified vascular and muscular structural changes alongside anti-Chlamydobacterials antibodies in 60% of patients, implicating immune mechanisms and infection in disease pathogenesis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The uterine appendages in 87 females aged from 17 to 53 years were surgically removed because of inefficacy of conservative treatment for purulent inflammation. There were signs of chronic recurrent inflammation in the uterine tubes or in the tubes and ovaries as shown by the operative material studied light and electron microscopically, immunomorphologically. Immune mechanisms as well as structural changes (reduction, vasculitis) of the vascular bed and muscular layer (sclerosis) of the tubes played a role in the pathogenesis of chronic inflammation. The detection of the antibodies against Chlamydobacterials in 60% of the patients implies their role in pathogenesis of chronic inflammation of the uterine appendages.

My notes (saved in your browser only)

MeSH descriptors

Pelvic Inflammatory Disease Adolescent Adult Antibodies, Bacterial Antibodies, Bacterial Chronic Disease Female Humans Middle Aged Morphogenesis Pelvic Inflammatory Disease Pelvic Inflammatory Disease Pelvic Inflammatory Disease Recurrence Sclerosis Sclerosis Vasculitis Vasculitis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:59:14.651011+00:00
License: CC0 · commercial use OK